Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | CFTR | P13569 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19353458 | 0.97 | CA2 (0.62) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL190428 | 0.97 | CA2 (0.62) | CA2CA4CA5AESR1CFTR | |
| Ammonia Solution, Strong SCHEMBL28000747 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL19895698 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| Hydrochloric Acid SCHEMBL11774248 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL190561 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL191018 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL191538 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL28468342 | 0.95 | CA2 (0.59) | CA2CA4CA5AESR1CFTR | |
| SCHEMBL28055666 | 0.88 | CA2 (0.52) | CA2CA4CA5AESR1CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011361-A | Phosphorus-containing flame-retardant nano fluid and preparation method and application thereof | 华侨大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4169977-B1 | RESIN COMPOSITION, MOLDED BODY AND ELECTROMAGNETIC WAVE ABSORBER | MITSUBISHI CHEM CORP (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4700081-A1 | THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PREPARING SAME, AND MOLDED ARTICLE COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| US-12559623-B2 | Resin composition and electromagnetic wave absorber | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-4685188-A1 | THERMOPLASTIC RESIN COMPOSITION, PREPARATION METHOD THEREFOR AND MOLDED ARTICLE COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-01-28 | — | — | EP | disclosed |
| US-12534597-B2 | Polyamide resin composition and molded object thereof | KURARAY CO., LTD. (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-4663703-A1 | POLYAMIDE RESIN COMPOSITION AND MOLDED ARTICLE | Mitsui Chemicals, Inc. (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-12446643-B2 | Core-sheath composite fiber for artificial hair and headwear product that includes same | KANEKA CORPORATION (JP) | 2025-10-21 | — | — | US | disclosed |
| US-12441065-B2 | Formed article, welding method, and method of manufacturing formed article | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12365169-B2 | Decorative sheet and decorative plate | DAI NIPPON PRINTING CO., LTD. (JP) | 2025-07-22 | — | — | US | disclosed |
| US-20090312468-A1 | FLAME RETARDANT POLYAMIDE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2009-12-17 | — | — | US | disclosed |
| US-20090305016-A1 | Heat-Resistant Resin Composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20090275682-A1 | Resin Composition Excellent in Flame Retardance | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20090081462-A1 | LONG FIBER FILLER REINFORCED RESIN PELLET | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20090029138-A1 | Resin Composition Having Excellent Heat Resistance | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1995280-A1 | FLAME RETARDANT POLYAMIDE RESIN COMPOSITION AND MOLDING | Mitsubishi Engineering-Plastics Corporation (JP) | 2008-11-26 | — | — | EP | disclosed |
| EP-1956048-A1 | RESIN COMPOSITION EXCELLENT IN FLAME RETARDANCE | Asahi Kasei Chemicals Corporation (JP) | 2008-08-13 | — | — | EP | disclosed |
| EP-1950249-A1 | RESIN COMPOSITION HAVING EXCELLENT HEAT RESISTANCE | Asahi Kasei Chemicals Corporation (JP) | 2008-07-30 | — | — | EP | disclosed |
| EP-1950248-A1 | HEAT-RESISTANT RESIN COMPOSITION | Asahi Kasei Chemicals Corporation (JP) | 2008-07-30 | — | — | EP | disclosed |
| US-20070235893-A1 | Method for producing resin strand | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534597-B2 | Polyamide resin composition and molded object thereof | SMC2, DAP3, RPTOR | CA2 162/4885CA4 408/4885CA5A 3049/4885 |
| US-12559623-B2 | Resin composition and electromagnetic wave absorber | TERB1, LBR, TEX10 | CA2 4247/4885CA4 3593/4885CA5A 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.